{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,11]],"date-time":"2026-11-11T08:58:32Z","timestamp":1794387512119,"version":"4.9.0"},"reference-count":106,"publisher":"Elsevier BV","issue":"6","license":[{"start":{"date-parts":[[2024,9,1]],"date-time":"2024-09-01T00:00:00Z","timestamp":1725148800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2024,9,1]],"date-time":"2024-09-01T00:00:00Z","timestamp":1725148800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["clinicalkey.fr","clinicalkey.jp","clinicalkey.es","clinicalkey.com.au","clinicalkey.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Archives of Medical Research"],"published-print":{"date-parts":[[2024,9]]},"DOI":"10.1016\/j.arcmed.2024.103043","type":"journal-article","created":{"date-parts":[[2024,8,1]],"date-time":"2024-08-01T16:11:04Z","timestamp":1722528664000},"page":"103043","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":192,"title":["Global Prevalence of Nonalcoholic Fatty Liver Disease: An Updated Review Meta-Analysis comprising a Population of 78 million from 38 Countries"],"prefix":"10.1016","volume":"55","author":[{"given":"Ehsan","family":"Amini-Salehi","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Negin","family":"Letafatkar","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Naeim","family":"Norouzi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Farahnaz","family":"Joukar","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Arman","family":"Habibi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mona","family":"Javid","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-7336-2219","authenticated-orcid":false,"given":"Nazila","family":"Sattari","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mehrdad","family":"Khorasani","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ali","family":"Farahmand","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shervin","family":"Tavakoli","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Behnaz","family":"Masoumzadeh","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-7387-8223","authenticated-orcid":false,"given":"Elaheh","family":"Abbaspour","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sahand","family":"Karimzad","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Amir","family":"Ghadiri","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0009-0007-9492-2733","authenticated-orcid":false,"given":"Gautam","family":"Maddineni","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mohammad Javad","family":"Khosousi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Niloofar","family":"Faraji","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mohammad-Hossein","family":"Keivanlou","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Abinash","family":"Mahapatro","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mohamad Amin Khajavi","family":"Gaskarei","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Paria","family":"Okhovat","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ali","family":"Bahrampourian","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-9600-1857","authenticated-orcid":false,"given":"Maryam Sadat","family":"Aleali","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-6608-8477","authenticated-orcid":false,"given":"Arian","family":"Mirdamadi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Narges","family":"Eslami","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mohamadreza","family":"Javid","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Naz","family":"Javaheri","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shrinidhi Vilas","family":"Pra","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Arash","family":"Bakhsi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mohammad","family":"Shafipour","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Azin","family":"Vakilpour","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Malek Moein","family":"Ansar","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-9901-0916","authenticated-orcid":false,"given":"Sai Guatham","family":"Kanagala","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mohamad","family":"Hashemi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Arezoo","family":"Ghazalgoo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Masoumeh","family":"Kheirandish","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Parham","family":"Porteghali","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Forough","family":"Heidarzad","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Taraneh","family":"Zeinali","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Fariborz Mansour","family":"Ghanaei","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Soheil","family":"Hassanipour","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-8523-5807","authenticated-orcid":false,"given":"Michael.T","family":"Ulrich","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Joshua E.","family":"Melson","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Dhruvan","family":"Patel","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sandeep Samethadka","family":"Nayak","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.arcmed.2024.103043_bib0001","doi-asserted-by":"crossref","first-page":"1335","DOI":"10.1097\/HEP.0000000000000004","article-title":"The global epidemiology of nonalcoholic fatty liver disease (NAFLD) and nonalcoholic steatohepatitis (NASH): a systematic review","volume":"77","author":"Younossi","year":"2023","journal-title":"Hepatology"},{"issue":"24","key":"10.1016\/j.arcmed.2024.103043_bib0002","doi-asserted-by":"crossref","DOI":"10.3390\/ijms232415489","article-title":"Non-Alcoholic Fatty Liver Disease (NAFLD) Pathogenesis and Natural Products for Prevention and Treatment","volume":"23","author":"Guo","year":"2022","journal-title":"Int J Mol Sci"},{"key":"10.1016\/j.arcmed.2024.103043_bib0003","doi-asserted-by":"crossref","first-page":"885","DOI":"10.1007\/s11154-023-09820-6","article-title":"Towards precision medicine in non-alcoholic fatty liver disease","volume":"24","author":"Francque","year":"2023","journal-title":"Rev Endocr Metab Disord"},{"key":"10.1016\/j.arcmed.2024.103043_bib0004","doi-asserted-by":"crossref","first-page":"63","DOI":"10.1186\/s12902-022-00980-1","article-title":"Non-alcoholic fatty liver disease (NAFLD): a review of pathophysiology, clinical management and effects of weight loss","volume":"22","author":"Pouwels","year":"2022","journal-title":"BMC Endocr Disord"},{"key":"10.1016\/j.arcmed.2024.103043_bib0005","first-page":"85","article-title":"Genetic risk factors associated with NAFLD. Genetic risk factors associated with","volume":"6","author":"Dong Yun","year":"2020","journal-title":"NAFLD"},{"key":"10.1016\/j.arcmed.2024.103043_bib0006","doi-asserted-by":"crossref","first-page":"5227","DOI":"10.3390\/ijerph18105227","article-title":"Non-Alcoholic Fatty Liver Disease: Metabolic, Genetic, Epigenetic and Environmental Risk Factors","volume":"18","author":"Juanola","year":"2021","journal-title":"Int J Environ Res Public Health"},{"key":"10.1016\/j.arcmed.2024.103043_bib0007","doi-asserted-by":"crossref","first-page":"72","DOI":"10.1002\/ncp.10449","article-title":"Evolution of NAFLD and Its Management","volume":"35","author":"Mundi","year":"2020","journal-title":"Nutr Clin Pract"},{"key":"10.1016\/j.arcmed.2024.103043_bib0008","doi-asserted-by":"crossref","DOI":"10.5812\/hepatmon-131523","article-title":"Risk Factors of Non-alcoholic Fatty Liver Disease in the Iranian Adult Population: A Systematic Review and Meta-analysis","volume":"23","author":"Amini-Salehi","year":"2023","journal-title":"Hepat Mon"},{"key":"10.1016\/j.arcmed.2024.103043_bib0009","doi-asserted-by":"crossref","first-page":"1587","DOI":"10.1016\/j.tjnut.2023.03.038","article-title":"A Healthy Diet is Associated with a Lower Risk of Hepatic Fibrosis","volume":"153","author":"Gao","year":"2023","journal-title":"J Nutr"},{"key":"10.1016\/j.arcmed.2024.103043_bib0010","series-title":"Handbook of Epidemiology","first-page":"1","article-title":"Epidemiology of Obesity","author":"Kim","year":"2019"},{"issue":"7","key":"10.1016\/j.arcmed.2024.103043_bib0011","article-title":"Non-Alcoholic Fatty Liver Disease in Children","volume":"57","author":"Brecelj","year":"2021","journal-title":"Medicina (Kaunas)"},{"key":"10.1016\/j.arcmed.2024.103043_bib0012","doi-asserted-by":"crossref","first-page":"2150","DOI":"10.1016\/j.cgh.2023.04.005","article-title":"Liver Transplantation 2023: Status Report, Current and Future Challenges","volume":"21","author":"Terrault","year":"2023","journal-title":"Clin Gastroenterol Hepatol"},{"key":"10.1016\/j.arcmed.2024.103043_bib0013","doi-asserted-by":"crossref","first-page":"1245","DOI":"10.1016\/j.jhep.2016.07.033","article-title":"NAFLD and liver transplantation: Current burden and expected challenges","volume":"65","author":"Pais","year":"2016","journal-title":"J Hepatol"},{"key":"10.1016\/j.arcmed.2024.103043_bib0014","doi-asserted-by":"crossref","first-page":"1245","DOI":"10.1016\/j.jhep.2016.07.033","article-title":"NAFLD and liver transplantation: Current burden and expected challenges","volume":"65","author":"Pais","year":"2016","journal-title":"J Hepatol"},{"key":"10.1016\/j.arcmed.2024.103043_bib0015","doi-asserted-by":"crossref","first-page":"912","DOI":"10.1053\/j.gastro.2020.11.051","article-title":"AGA Clinical Practice Update on Lifestyle Modification Using Diet and Exercise to Achieve Weight Loss in the Management of Nonalcoholic Fatty Liver Disease: Expert Review","volume":"160","author":"Younossi","year":"2021","journal-title":"Gastroenterology"},{"key":"10.1016\/j.arcmed.2024.103043_bib0016","doi-asserted-by":"crossref","first-page":"11","DOI":"10.1111\/cts.12839","article-title":"Evolving Role for Pharmacotherapy in NAFLD\/NASH","volume":"14","author":"Attia","year":"2021","journal-title":"Clin Transl Sci"},{"key":"10.1016\/j.arcmed.2024.103043_bib0017","doi-asserted-by":"crossref","DOI":"10.1016\/j.jhepr.2020.100192","article-title":"NAFLD and liver transplantation: Disease burden, current management and future challenges","volume":"2","author":"Burra","year":"2020","journal-title":"JHEP Reports"},{"key":"10.1016\/j.arcmed.2024.103043_bib0018","first-page":"1600","article-title":"The Prevalence of Non-Alcoholic Fatty Liver Disease in Iranian Children and Adult Population: A Systematic Review and Meta-Analysis","volume":"52","author":"Hassanipour","year":"2023","journal-title":"Iran J Public Health"},{"key":"10.1016\/j.arcmed.2024.103043_bib0019","doi-asserted-by":"crossref","first-page":"851","DOI":"10.1016\/S2468-1253(22)00165-0","article-title":"The prevalence and incidence of NAFLD worldwide: a systematic review and meta-analysis","volume":"7","author":"Riazi","year":"2022","journal-title":"Lancet Gastroenterol Hepatol"},{"key":"10.1016\/j.arcmed.2024.103043_bib0020","doi-asserted-by":"crossref","first-page":"2809","DOI":"10.1016\/j.cgh.2021.12.002","article-title":"2019 Global NAFLD prevalence: a systematic review and meta-analysis","volume":"20","author":"Le","year":"2022","journal-title":"Clin Gastroenterol Hepatol"},{"key":"10.1016\/j.arcmed.2024.103043_bib0021","doi-asserted-by":"crossref","unstructured":"Shuster JJ. Cochrane handbook for systematic reviews for interventions, Version 5.1. 0, published 3\/2011. Julian PT Higgins and Sally Green, Editors. Wiley Online Library. 2011.","DOI":"10.1002\/jrsm.38"},{"key":"10.1016\/j.arcmed.2024.103043_bib0022","doi-asserted-by":"crossref","first-page":"W-65-W-94","DOI":"10.7326\/0003-4819-151-4-200908180-00136","article-title":"The PRISMA statement for reporting systematic reviews and meta-analyses of studies that evaluate health care interventions: explanation and elaboration","volume":"151","author":"Liberati","year":"2009","journal-title":"Ann Intern Med"},{"key":"10.1016\/j.arcmed.2024.103043_bib0023","unstructured":"Institute TJB. The Joanna Briggs Institute Critical Appraisal tools for use in JBI Systematic Reviews; Checklist for Analytical Cross Sectional Studies 2017 [Available from: https:\/\/jbi.global\/sites\/default\/files\/2019-05\/JBI_Critical_Appraisal-Checklist_for_Analytical_Cross_Sectional_Studies2017_0.pdf."},{"key":"10.1016\/j.arcmed.2024.103043_bib0024","unstructured":"Institute TJB. The Joanna Briggs Institute Critical Appraisal tools for use in JBI Systematic Reviews; Checklist for Cohort Studies 2017 [Available from: https:\/\/jbi.global\/sites\/default\/files\/2019-05\/JBI_Critical_Appraisal-Checklist_for_Cohort_Studies2017_0.pdf."},{"key":"10.1016\/j.arcmed.2024.103043_bib0025","doi-asserted-by":"crossref","first-page":"e192","DOI":"10.1016\/j.jhep.2024.01.012","article-title":"Researchers call for more flexible editorial conduct rather than abruptly adopting only the new MASLD nomenclature","volume":"80","author":"Lonardo","year":"2024","journal-title":"J Hepatol"},{"key":"10.1016\/j.arcmed.2024.103043_bib0026","doi-asserted-by":"crossref","first-page":"150","DOI":"10.1111\/apt.17846","article-title":"Implications of the new nomenclature of steatotic liver disease and definition of metabolic dysfunction-associated steatotic liver disease","volume":"59","author":"Loomba","year":"2024","journal-title":"Aliment Pharmacol Ther"},{"key":"10.1016\/j.arcmed.2024.103043_bib0027","doi-asserted-by":"crossref","first-page":"1253","DOI":"10.4254\/wjh.v15.i12.1253","article-title":"From metabolic dysfunction-associated fatty liver disease to metabolic dysfunction-associated steatotic liver disease: Controversy and consensus","volume":"15","author":"Chen","year":"2023","journal-title":"World J Hepatol"},{"key":"10.1016\/j.arcmed.2024.103043_bib0028","doi-asserted-by":"crossref","DOI":"10.1016\/j.aohep.2023.101281","article-title":"From NAFLD to MASLD: When metabolic comorbidity matters","volume":"29","author":"Hong","year":"2024","journal-title":"Ann Hepatol"},{"key":"10.1016\/j.arcmed.2024.103043_bib0029","doi-asserted-by":"crossref","first-page":"1397","DOI":"10.2169\/internalmedicine.6118-20","article-title":"Progression from Nonalcoholic Fatty Liver to Nonalcoholic Steatohepatitis Cirrhosis Confirmed by Liver Histology after 14 Years","volume":"60","author":"Kawanaka","year":"2021","journal-title":"Intern Med"},{"key":"10.1016\/j.arcmed.2024.103043_bib0030","doi-asserted-by":"crossref","first-page":"1335","DOI":"10.1097\/HEP.0000000000000004","article-title":"The global epidemiology of nonalcoholic fatty liver disease (NAFLD) and nonalcoholic steatohepatitis (NASH): a systematic review","volume":"77","author":"Younossi","year":"2023","journal-title":"Hepatology"},{"key":"10.1016\/j.arcmed.2024.103043_bib0031","doi-asserted-by":"crossref","first-page":"1553","DOI":"10.1111\/j.1365-2036.2006.03161.x","article-title":"Effect of vitamin E on aminotransferase levels and insulin resistance in children with non-alcoholic fatty liver disease","volume":"24","author":"Nobili","year":"2006","journal-title":"Aliment Pharmacol Ther"},{"key":"10.1016\/j.arcmed.2024.103043_bib0032","doi-asserted-by":"crossref","first-page":"305","DOI":"10.1016\/j.jadohealth.2012.01.010","article-title":"Nonalcoholic fatty liver in children and adolescents: an overview","volume":"51","author":"Della Corte","year":"2012","journal-title":"J Adolesc Health"},{"key":"10.1016\/j.arcmed.2024.103043_bib0033","doi-asserted-by":"crossref","first-page":"396","DOI":"10.1111\/apt.17096","article-title":"Meta-analysis: global prevalence, trend and forecasting of non-alcoholic fatty liver disease in children and adolescents, 2000\u20132021","volume":"56","author":"Li","year":"2022","journal-title":"Aliment Pharmacol Ther"},{"key":"10.1016\/j.arcmed.2024.103043_bib0034","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0140908","article-title":"The Prevalence of Non-Alcoholic Fatty Liver Disease in Children and Adolescents: A Systematic Review and Meta-Analysis","volume":"10","author":"Anderson","year":"2015","journal-title":"PLoS One"},{"key":"10.1016\/j.arcmed.2024.103043_bib0035","doi-asserted-by":"crossref","first-page":"519","DOI":"10.1016\/j.clnesp.2021.08.028","article-title":"High prevalence of hepatic steatosis and hepatic fibrosis in patients with type 2 diabetes mellitus","volume":"46","author":"Gupta","year":"2021","journal-title":"Clin Nutr ESPEN"},{"key":"10.1016\/j.arcmed.2024.103043_bib0036","doi-asserted-by":"crossref","first-page":"643","DOI":"10.1016\/j.cgh.2014.04.014","article-title":"Fibrosis progression in nonalcoholic fatty liver vs nonalcoholic steatohepatitis: a systematic review and meta-analysis of paired-biopsy studies","volume":"13","author":"Singh","year":"2015","journal-title":"Clin Gastroenterol Hepatol"},{"key":"10.1016\/j.arcmed.2024.103043_bib0037","doi-asserted-by":"crossref","first-page":"3238","DOI":"10.3748\/wjg.v27.i23.3238","article-title":"Clinical indicators for progression of nonalcoholic steatohepatitis to cirrhosis","volume":"27","author":"Seen","year":"2021","journal-title":"World J Gastroenterol"},{"key":"10.1016\/j.arcmed.2024.103043_bib0038","doi-asserted-by":"crossref","first-page":"2584","DOI":"10.1007\/s10620-021-07032-z","article-title":"Comorbidities Are Associated with Fibrosis in NAFLD Subjects: A Nationwide Study (NASH-CO Study)","volume":"67","author":"Nabi","year":"2022","journal-title":"Dig Dis Sci"},{"key":"10.1016\/j.arcmed.2024.103043_bib0039","doi-asserted-by":"crossref","first-page":"389","DOI":"10.1016\/S2468-1253(19)30039-1","article-title":"Prevalence, incidence, and outcome of non-alcoholic fatty liver disease in Asia, 1999\u20132019: a systematic review and meta-analysis","volume":"4","author":"Li","year":"2019","journal-title":"Lancet Gastroenterol Hepatol"},{"key":"10.1016\/j.arcmed.2024.103043_bib0040","doi-asserted-by":"crossref","first-page":"1119","DOI":"10.1002\/hep.30702","article-title":"Unexpected rapid increase in the burden of NAFLD in China from 2008 to 2018: a systematic review and meta-analysis","volume":"70","author":"Zhou","year":"2019","journal-title":"Hepatology"},{"key":"10.1016\/j.arcmed.2024.103043_bib0041","first-page":"404","article-title":"Epidemiology of nonalcoholic fatty liver disease in Europe: a systematic review and meta-analysis","volume":"34","author":"Cholongitas","year":"2021","journal-title":"Ann Gastroenterol"},{"key":"10.1016\/j.arcmed.2024.103043_bib0042","doi-asserted-by":"crossref","first-page":"61","DOI":"10.1016\/j.cgh.2020.04.067","article-title":"Women Have a Lower Risk of Nonalcoholic Fatty Liver Disease but a Higher Risk of Progression vs Men: A Systematic Review and Meta-analysis","volume":"19","author":"Balakrishnan","year":"2021","journal-title":"Clin Gastroenterol Hepatol"},{"key":"10.1016\/j.arcmed.2024.103043_bib0043","doi-asserted-by":"crossref","first-page":"47","DOI":"10.1038\/s41574-020-00431-8","article-title":"Sexual dimorphism in cardiometabolic health: the role of adipose tissue, muscle and liver","volume":"17","author":"Goossens","year":"2021","journal-title":"Nat Rev Endocrinol"},{"key":"10.1016\/j.arcmed.2024.103043_bib0044","doi-asserted-by":"crossref","first-page":"1649","DOI":"10.1053\/gast.2002.33573","article-title":"Nonalcoholic fatty liver disease","volume":"122","author":"Clark","year":"2002","journal-title":"Gastroenterology"},{"key":"10.1016\/j.arcmed.2024.103043_bib0045","doi-asserted-by":"crossref","first-page":"1291","DOI":"10.1007\/s12325-017-0556-1","article-title":"NAFLD as a sexual dimorphic disease: role of gender and reproductive status in the development and progression of nonalcoholic fatty liver disease and inherent cardiovascular risk","volume":"34","author":"Ballestri","year":"2017","journal-title":"Adv Ther"},{"issue":"Suppl 1","key":"10.1016\/j.arcmed.2024.103043_bib0046","first-page":"S19","article-title":"Gender Differences in Nonalcoholic Fatty Liver Disease","volume":"12","author":"Nagral","year":"2022","journal-title":"Euroasian J Hepatogastroenterol"},{"issue":"5","key":"10.1016\/j.arcmed.2024.103043_bib0047","doi-asserted-by":"crossref","DOI":"10.3390\/jcm9051278","article-title":"Sexual Dimorphism of NAFLD in Adults. Focus on Clinical Aspects and Implications for Practice and Translational Research","volume":"9","author":"Lonardo","year":"2020","journal-title":"J Clin Med"},{"key":"10.1016\/j.arcmed.2024.103043_bib0048","doi-asserted-by":"crossref","first-page":"348","DOI":"10.1097\/GME.0000000000002133","article-title":"Menopause is associated with increased prevalence of nonalcoholic fatty liver disease: a systematic review and meta-analysis","volume":"30","author":"Jaroenlapnopparat","year":"2023","journal-title":"Menopause"},{"issue":"10","key":"10.1016\/j.arcmed.2024.103043_bib0049","doi-asserted-by":"crossref","DOI":"10.1210\/endocr\/bqaa134","article-title":"Women: Implications for Diagnosis and Treatment","volume":"161","author":"DiStefano","year":"2020","journal-title":"Endocrinology"},{"issue":"10","key":"10.1016\/j.arcmed.2024.103043_bib0050","doi-asserted-by":"crossref","DOI":"10.3390\/ijerph18105227","article-title":"Non-Alcoholic Fatty Liver Disease: Metabolic, Genetic, Epigenetic and Environmental Risk Factors","volume":"18","author":"Juanola","year":"2021","journal-title":"Int J Environ Res Public Health"},{"key":"10.1016\/j.arcmed.2024.103043_bib0051","doi-asserted-by":"crossref","first-page":"1","DOI":"10.3350\/cmh.2016.0109","article-title":"Genetic predisposition in nonalcoholic fatty liver disease","volume":"23","author":"Sookoian","year":"2017","journal-title":"Clin Mol Hepatol"},{"issue":"suppl_1","key":"10.1016\/j.arcmed.2024.103043_bib0052","doi-asserted-by":"crossref","first-page":"ckt126.346","DOI":"10.1093\/eurpub\/ckt126.346","article-title":"Overview of lifestyle and risk factors for Men's Health and directions for Health Promotion\u2013Concepts, Research Projects and Best Practice Examples. Noel Richardson","volume":"23","author":"Richardson","year":"2013","journal-title":"Eur J Public Health"},{"key":"10.1016\/j.arcmed.2024.103043_bib0053","doi-asserted-by":"crossref","first-page":"145","DOI":"10.1146\/annurev-pathol-121808-102132","article-title":"Nonalcoholic fatty liver disease: pathology and pathogenesis","volume":"5","author":"Tiniakos","year":"2010","journal-title":"Annu Rev Pathol"},{"key":"10.1016\/j.arcmed.2024.103043_bib0054","doi-asserted-by":"crossref","first-page":"449","DOI":"10.1002\/hep.22350","article-title":"Visceral fat: a key mediator of steatohepatitis in metabolic liver disease","volume":"48","author":"van der Poorten","year":"2008","journal-title":"Hepatology"},{"key":"10.1016\/j.arcmed.2024.103043_bib0055","doi-asserted-by":"crossref","first-page":"1345","DOI":"10.1002\/oby.21133","article-title":"Shaping fat distribution: New insights into the molecular determinants of depot- and sex-dependent adipose biology","volume":"23","author":"Fried","year":"2015","journal-title":"Obesity (Silver Spring)"},{"key":"10.1016\/j.arcmed.2024.103043_bib0056","doi-asserted-by":"crossref","first-page":"417","DOI":"10.1146\/annurev.nu.09.070189.002221","article-title":"Physiologic basis for the control of body fat distribution in humans","volume":"9","author":"Leibel","year":"1989","journal-title":"Annu Rev Nutr"},{"key":"10.1016\/j.arcmed.2024.103043_bib0057","doi-asserted-by":"crossref","first-page":"1457","DOI":"10.1002\/hep.30626","article-title":"Sex Differences in Nonalcoholic Fatty Liver Disease: State of the Art and Identification of Research Gaps","volume":"70","author":"Lonardo","year":"2019","journal-title":"Hepatology"},{"key":"10.1016\/j.arcmed.2024.103043_bib0058","doi-asserted-by":"crossref","first-page":"1869","DOI":"10.1210\/jc.2003-031327","article-title":"Estrogen controls lipolysis by up-regulating alpha2A-adrenergic receptors directly in human adipose tissue through the estrogen receptor alpha. Implications for the female fat distribution","volume":"89","author":"Pedersen","year":"2004","journal-title":"J Clin Endocrinol Metab"},{"key":"10.1016\/j.arcmed.2024.103043_bib0059","article-title":"Estradiol-mediated improvements in adipose tissue insulin sensitivity are related to the balance of adipose tissue estrogen receptor \u03b1 and \u03b2 in postmenopausal women","volume":"12","author":"Park","year":"2017","journal-title":"PLoS One"},{"key":"10.1016\/j.arcmed.2024.103043_bib0060","doi-asserted-by":"crossref","first-page":"4753","DOI":"10.1210\/jc.2006-0587","article-title":"Review: The role of insulin resistance in nonalcoholic fatty liver disease","volume":"91","author":"Utzschneider","year":"2006","journal-title":"J Clin Endocrinol Metab"},{"key":"10.1016\/j.arcmed.2024.103043_bib0061","doi-asserted-by":"crossref","first-page":"592","DOI":"10.1152\/japplphysiol.01046.2012","article-title":"Adiponectin concentration is associated with muscle insulin sensitivity, AMPK phosphorylation, and ceramide content in skeletal muscles of men but not women","volume":"114","author":"H\u00f8eg","year":"2013","journal-title":"J Appl Physiol (1985)"},{"issue":"2_suppl","key":"10.1016\/j.arcmed.2024.103043_bib0062","doi-asserted-by":"crossref","first-page":"7","DOI":"10.1177\/2047487319881021","article-title":"The global epidemics of diabetes in the 21st century: Current situation and perspectives","volume":"26","author":"Standl","year":"2019","journal-title":"Eur J Prev Cardiol"},{"key":"10.1016\/j.arcmed.2024.103043_bib0063","doi-asserted-by":"crossref","first-page":"107","DOI":"10.2991\/jegh.k.191028.001","article-title":"Epidemiology of Type 2 Diabetes - Global Burden of Disease and Forecasted Trends","volume":"10","author":"Khan","year":"2020","journal-title":"J Epidemiol Glob Health"},{"key":"10.1016\/j.arcmed.2024.103043_bib0064","doi-asserted-by":"crossref","first-page":"276","DOI":"10.1007\/s13679-018-0317-8","article-title":"Epidemiology of Obesity in Adults: Latest Trends","volume":"7","author":"Inoue","year":"2018","journal-title":"Curr Obes Rep"},{"issue":"3","key":"10.1016\/j.arcmed.2024.103043_bib0065","doi-asserted-by":"crossref","DOI":"10.3390\/nu15030640","article-title":"New Advances in Metabolic Syndrome, from Prevention to Treatment: The Role of Diet and Food","volume":"15","author":"Ambroselli","year":"2023","journal-title":"Nutrients"},{"issue":"10","key":"10.1016\/j.arcmed.2024.103043_bib0066","doi-asserted-by":"crossref","DOI":"10.3390\/biomedicines10102436","article-title":"Current Advances in the Management of Diabetes Mellitus","volume":"10","author":"Aloke","year":"2022","journal-title":"Biomedicines"},{"key":"10.1016\/j.arcmed.2024.103043_bib0067","doi-asserted-by":"crossref","first-page":"133","DOI":"10.5694\/mja2.50472","article-title":"Advances in type 2 diabetes therapy: a focus on cardiovascular and renal outcomes","volume":"212","author":"Libianto","year":"2020","journal-title":"Med J Aust"},{"key":"10.1016\/j.arcmed.2024.103043_bib0068","doi-asserted-by":"crossref","first-page":"237","DOI":"10.1089\/chi.2021.0190","article-title":"Advanced Obesity Treatment Selection among Adolescents in a Pediatric Weight Management Program","volume":"18","author":"Suarez","year":"2022","journal-title":"Child Obes"},{"key":"10.1016\/j.arcmed.2024.103043_bib0069","doi-asserted-by":"crossref","first-page":"36","DOI":"10.1093\/toxsci\/kfx233","article-title":"Metabolic Syndrome and Associated Diseases: From the Bench to the Clinic","volume":"162","author":"Mendrick","year":"2018","journal-title":"Toxicol Sci"},{"key":"10.1016\/j.arcmed.2024.103043_bib0070","first-page":"110","article-title":"Effectiveness of diabetes education and awareness of diabetes mellitus in combating diabetes in the United Kigdom; a literature review","volume":"5","author":"Nazar","year":"2016","journal-title":"J Nephropharmacol"},{"issue":"3","key":"10.1016\/j.arcmed.2024.103043_bib0071","doi-asserted-by":"crossref","DOI":"10.3390\/ijms24032844","article-title":"Advances in the Diagnosis and Treatment of Non-Alcoholic Fatty Liver Disease","volume":"24","author":"Yin","year":"2023","journal-title":"Int J Mol Sci"},{"key":"10.1016\/j.arcmed.2024.103043_bib0072","doi-asserted-by":"crossref","first-page":"1168","DOI":"10.1097\/HEP.0000000000000383","article-title":"Global and national prevalence of nonalcoholic fatty liver disease in adolescents: An analysis of the global burden of disease study 2019","volume":"78","author":"Hartmann","year":"2023","journal-title":"Hepatology"},{"key":"10.1016\/j.arcmed.2024.103043_bib0073","doi-asserted-by":"crossref","first-page":"98","DOI":"10.3961\/jpmph.19.100","article-title":"The Relationship Between Obesity, Overweight, and the Human Development Index in World Health Organization Eastern Mediterranean Region Countries","volume":"53","author":"Ataey","year":"2020","journal-title":"J Prev Med Public Health"},{"key":"10.1016\/j.arcmed.2024.103043_bib0074","doi-asserted-by":"crossref","first-page":"73","DOI":"10.1002\/hep.28431","article-title":"Global epidemiology of nonalcoholic fatty liver disease-Meta-analytic assessment of prevalence, incidence, and outcomes","volume":"64","author":"Younossi","year":"2016","journal-title":"Hepatology"},{"key":"10.1016\/j.arcmed.2024.103043_bib0075","doi-asserted-by":"crossref","first-page":"11","DOI":"10.1038\/nrgastro.2017.109","article-title":"Global burden of NAFLD and NASH: trends, predictions, risk factors and prevention","volume":"15","author":"Younossi","year":"2018","journal-title":"Nat Rev Gastroenterol Hepatol"},{"key":"10.1016\/j.arcmed.2024.103043_bib0076","doi-asserted-by":"crossref","first-page":"1305","DOI":"10.1111\/apt.15738","article-title":"Review article: the emerging role of genetics in precision medicine for patients with non-alcoholic steatohepatitis","volume":"51","author":"Carlsson","year":"2020","journal-title":"Aliment Pharmacol Ther"},{"key":"10.1016\/j.arcmed.2024.103043_bib0077","doi-asserted-by":"crossref","first-page":"694","DOI":"10.1038\/s43016-022-00594-9","article-title":"Global dietary quality in 185 countries from 1990 to 2018 show wide differences by nation, age, education, and urbanicity","volume":"3","author":"Miller","year":"2022","journal-title":"Nat Food"},{"key":"10.1016\/j.arcmed.2024.103043_bib0078","doi-asserted-by":"crossref","first-page":"1388","DOI":"10.1016\/j.jhep.2015.11.004","article-title":"EASL-EASD-EASO Clinical Practice Guidelines for the management of non-alcoholic fatty liver disease","volume":"64","year":"2016","journal-title":"J Hepatol"},{"key":"10.1016\/j.arcmed.2024.103043_bib0079","doi-asserted-by":"crossref","first-page":"1209","DOI":"10.1111\/apt.12963","article-title":"Performance and limitations of steatosis biomarkers in patients with nonalcoholic fatty liver disease","volume":"40","author":"Fedchuk","year":"2014","journal-title":"Aliment Pharmacol Ther"},{"key":"10.1016\/j.arcmed.2024.103043_bib0080","first-page":"7","article-title":"Diagnostic accuracy of ultrasonography for the detection of hepatic steatosis: an updated meta-analysis of observational studies","volume":"1","author":"Ballestri","year":"2021","journal-title":"Metab Target Organ Damage"},{"key":"10.1016\/j.arcmed.2024.103043_bib0081","doi-asserted-by":"crossref","first-page":"1398","DOI":"10.1111\/liv.12226","article-title":"Predictive value of ALT levels for non-alcoholic steatohepatitis (NASH) and advanced fibrosis in non-alcoholic fatty liver disease (NAFLD)","volume":"33","author":"Verma","year":"2013","journal-title":"Liver Int"},{"key":"10.1016\/j.arcmed.2024.103043_bib0082","doi-asserted-by":"crossref","first-page":"211","DOI":"10.1136\/flgastro-2013-100403","article-title":"Non-alcoholic fatty liver disease: a practical approach to diagnosis and staging","volume":"5","author":"Dyson","year":"2014","journal-title":"Frontline Gastroenterol"},{"key":"10.1016\/j.arcmed.2024.103043_bib0083","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1186\/s12876-020-1165-z","article-title":"Proportion of NAFLD patients with normal ALT value in overall NAFLD patients: a systematic review and meta-analysis","volume":"20","author":"Ma","year":"2020","journal-title":"BMC Gastroenterol"},{"key":"10.1016\/j.arcmed.2024.103043_bib0084","doi-asserted-by":"crossref","first-page":"1286","DOI":"10.1053\/jhep.2003.50229","article-title":"Clinical and histologic spectrum of nonalcoholic fatty liver disease associated with normal ALT values","volume":"37","author":"Mofrad","year":"2003","journal-title":"Hepatology"},{"key":"10.1016\/j.arcmed.2024.103043_bib0085","doi-asserted-by":"crossref","first-page":"1387","DOI":"10.1002\/hep.20466","article-title":"Prevalence of hepatic steatosis in an urban population in the United States: impact of ethnicity","volume":"40","author":"Browning","year":"2004","journal-title":"Hepatology"},{"key":"10.1016\/j.arcmed.2024.103043_bib0086","doi-asserted-by":"crossref","first-page":"664","DOI":"10.3390\/metabo12070664","article-title":"Comparison of the diagnostic performance of steatosis indices for discrimination of CT-diagnosed metabolic dysfunction-associated fatty liver disease","volume":"12","author":"Han","year":"2022","journal-title":"Metabolites"},{"key":"10.1016\/j.arcmed.2024.103043_bib0087","doi-asserted-by":"crossref","first-page":"132","DOI":"10.3390\/diagnostics11010132","article-title":"Prediction of Nonalcoholic Fatty Liver Disease Using Noninvasive and Non-Imaging Procedures in Japanese Health Checkup Examinees","volume":"11","author":"Murayama","year":"2021","journal-title":"Diagnostics"},{"key":"10.1016\/j.arcmed.2024.103043_bib0088","doi-asserted-by":"crossref","first-page":"445","DOI":"10.1111\/hiv.13060","article-title":"Diagnostic value of serological biomarkers for detection of non-alcoholic fatty liver disease (NAFLD) and\/or advanced liver fibrosis in people living with HIV","volume":"22","author":"Yanavich","year":"2021","journal-title":"HIV medicine"},{"key":"10.1016\/j.arcmed.2024.103043_bib0089","first-page":"10","article-title":"The Fatty liver Index (FLI) 15 years later: a reappraisal","volume":"1","author":"Lonardo","year":"2021","journal-title":"Metab Target Organ Damage"},{"key":"10.1016\/j.arcmed.2024.103043_bib0090","doi-asserted-by":"crossref","first-page":"12","DOI":"10.20517\/mtod.2022.14","article-title":"Effect of cofactors on NAFLD\/NASH and MAFLD - a paradigm illustrating the pathomechanics of organ dysfunction","volume":"2","author":"Lonardo","year":"2022","journal-title":"Metab Target Organ Damage"},{"key":"10.1016\/j.arcmed.2024.103043_bib0091","doi-asserted-by":"crossref","first-page":"792","DOI":"10.4254\/wjh.v12.i10.792","article-title":"PNPLA3 and TM6SF2 polymorphisms in Brazilian patients with nonalcoholic fatty liver disease","volume":"12","author":"Lisboa","year":"2020","journal-title":"World J Hepatol"},{"issue":"10","key":"10.1016\/j.arcmed.2024.103043_bib0092","doi-asserted-by":"crossref","DOI":"10.3390\/biomedicines9101359","article-title":"Genetics Is of the Essence to Face NAFLD","volume":"9","author":"Meroni","year":"2021","journal-title":"Biomedicines"},{"issue":"3","key":"10.1016\/j.arcmed.2024.103043_bib0093","doi-asserted-by":"crossref","DOI":"10.3390\/nu11030677","article-title":"Impact of Nutritional Changes on Nonalcoholic Fatty Liver Disease","volume":"11","author":"Perdomo","year":"2019","journal-title":"Nutrients"},{"key":"10.1016\/j.arcmed.2024.103043_bib0094","doi-asserted-by":"crossref","DOI":"10.3389\/fnut.2021.640557","article-title":"The Impact of Macronutrient Intake on Non-alcoholic Fatty Liver Disease (NAFLD): Too Much Fat, Too Much Carbohydrate, or Just Too Many Calories?","volume":"8","author":"Hydes","year":"2021","journal-title":"Front Nutr"},{"key":"10.1016\/j.arcmed.2024.103043_bib0095","doi-asserted-by":"crossref","first-page":"144","DOI":"10.1186\/s13643-023-02299-x","article-title":"Effects of gut microbial therapy on lipid profile in individuals with non-alcoholic fatty liver disease: an umbrella meta-analysis study","volume":"12","author":"Naghipour","year":"2023","journal-title":"Syst Rev"},{"key":"10.1016\/j.arcmed.2024.103043_bib0096","doi-asserted-by":"crossref","first-page":"815","DOI":"10.1093\/nutrit\/nuad086","article-title":"The impact of gut microbiome-targeted therapy on liver enzymes in patients with nonalcoholic fatty liver disease: an umbrella meta-analysis","volume":"82","author":"Amini-Salehi","year":"2024","journal-title":"Nutr Rev"},{"key":"10.1016\/j.arcmed.2024.103043_bib0097","doi-asserted-by":"crossref","first-page":"475","DOI":"10.1016\/j.clnesp.2023.07.087","article-title":"Anti-inflammatory effects of probiotics and synbiotics on patients with non-alcoholic fatty liver disease: An umbrella study on meta-analyses","volume":"57","author":"Mahapatro","year":"2023","journal-title":"Clin Nutr ESPEN"},{"key":"10.1016\/j.arcmed.2024.103043_bib0098","doi-asserted-by":"crossref","DOI":"10.2174\/0115733998284844240102110559","article-title":"The Value of Microbiome-targeted Therapy on Lipid Indices of Patients with Type 2 Diabetes Mellitus: An Umbrella Meta-analysis of Randomized Controlled Trials","author":"Keivanlou","year":"2024","journal-title":"Curr Diabetes Rev"},{"key":"10.1016\/j.arcmed.2024.103043_bib0099","doi-asserted-by":"crossref","first-page":"2900","DOI":"10.1097\/MS9.0000000000001740","article-title":"Can modulation of gut microbiota affect anthropometric indices in patients with non-alcoholic fatty liver disease? An umbrella meta-analysis of randomized controlled trials","volume":"86","author":"Amini-Salehi","year":"2024","journal-title":"Ann Med Surg (Lond)"},{"key":"10.1016\/j.arcmed.2024.103043_bib0100","doi-asserted-by":"crossref","first-page":"25","DOI":"10.1038\/s41387-024-00281-7","article-title":"The effects of gut microbiome manipulation on glycemic indices in patients with non-alcoholic fatty liver disease: a comprehensive umbrella review","volume":"14","author":"Vakilpour","year":"2024","journal-title":"Nutr Diabetes"},{"key":"10.1016\/j.arcmed.2024.103043_bib0101","doi-asserted-by":"crossref","DOI":"10.1155\/2021\/5556354","article-title":"NAFLD and Infection, a Nuanced Relationship","volume":"2021","author":"Adenote","year":"2021","journal-title":"Can J Gastroenterol Hepatol"},{"key":"10.1016\/j.arcmed.2024.103043_bib0102","doi-asserted-by":"crossref","DOI":"10.3389\/fimmu.2022.954869","article-title":"The immune response as a therapeutic target in non-alcoholic fatty liver disease","volume":"13","author":"Ortiz-L\u00f3pez","year":"2022","journal-title":"Front Immunol"},{"key":"10.1016\/j.arcmed.2024.103043_bib0103","doi-asserted-by":"crossref","DOI":"10.1016\/j.metop.2021.100149","article-title":"Metabolic causes and consequences of nonalcoholic fatty liver disease (NAFLD)","volume":"12","author":"Zarghamravanbakhsh","year":"2021","journal-title":"Metabol Open"},{"key":"10.1016\/j.arcmed.2024.103043_bib0104","doi-asserted-by":"crossref","first-page":"5","DOI":"10.2337\/dsi23-0015","article-title":"Nonalcoholic Fatty Liver Disease in Diabetes: A Call to Action","volume":"37","author":"Cusi","year":"2024","journal-title":"Diabetes Spectrum"},{"key":"10.1016\/j.arcmed.2024.103043_bib0105","doi-asserted-by":"crossref","first-page":"19","DOI":"10.20517\/mtod.2022.24","article-title":"The growing prevalence of nonalcoholic fatty liver disease (NAFLD), determined by fatty liver index, amongst young adults in the United States. A 20-year experience","volume":"2","author":"Li","year":"2022","journal-title":"Metab Target Organ Damage"},{"key":"10.1016\/j.arcmed.2024.103043_bib0106","doi-asserted-by":"crossref","first-page":"891","DOI":"10.1080\/17512433.2023.2259306","article-title":"The heterogeneity of metabolic syndrome presentation and challenges this causes in its pharmacological management: a narrative review focusing on principal risk modifiers","volume":"16","author":"Lonardo","year":"2023","journal-title":"Expert Rev Clin Pharmacol"}],"container-title":["Archives of Medical Research"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S018844092400095X?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S018844092400095X?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2024,9,14]],"date-time":"2024-09-14T18:27:33Z","timestamp":1726338453000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S018844092400095X"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,9]]},"references-count":106,"journal-issue":{"issue":"6","published-print":{"date-parts":[[2024,9]]}},"alternative-id":["S018844092400095X"],"URL":"https:\/\/doi.org\/10.1016\/j.arcmed.2024.103043","relation":{},"ISSN":["0188-4409"],"issn-type":[{"value":"0188-4409","type":"print"}],"subject":[],"published":{"date-parts":[[2024,9]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Global Prevalence of Nonalcoholic Fatty Liver Disease: An Updated Review Meta-Analysis comprising a Population of 78 million from 38 Countries","name":"articletitle","label":"Article Title"},{"value":"Archives of Medical Research","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.arcmed.2024.103043","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2024 Instituto Mexicano del Seguro Social (IMSS). Published by Elsevier Inc. All rights are reserved, including those for text and data mining, AI training, and similar technologies.","name":"copyright","label":"Copyright"}],"article-number":"103043"}}